You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CYTK Exercise Disclosure
Callos Andrew · SEC Form 4 · Filed Jul 2, 2026
Exercise
Calculated transaction value
$0
Callos Andrew EVP, Chief Commercial Officer
CYTK
Cytokinetics Inc
CYTK
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
CYTK daily price context
Close on/before transaction
$85.26
Jul 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 15,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001061983-26-000073
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.64M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Jul 1, 2026 | $348.9K |
| Cytokinetics Inc CYTK | Sale | Jul 1, 2026 | $1.29M |
| Cytokinetics Inc CYTK Current | Exercise | Jul 1, 2026 | $0 |